NASDAQ:STRR

Star Equity Holdings (NASDAQ:STRR) Q2 2026 Earnings Miss: Revenue Growth Amidst Widening Net Loss

Font: Financial Modeling Prep  • Aug 14, 2026

Market Chart
  • Star Equity Holdings reported a significant miss on both earnings per share and revenue targets for its second quarter 2026 financial results.
  • Despite falling short of analyst revenue expectations, the company demonstrated robust top-line growth with a 54.6% year-over-year increase in sales.
  • Profitability challenges persisted, marked by a widening net loss and a negative Price-to-Earnings ratio, even as the company pursues strategic expansion through acquisition.

Star Equity Holdings (NASDAQ:STRR) is a diversified holding company, meaning it owns a variety of businesses in different sectors. On August 14, 2026, Star Equity Holdings announced its Q2 2026 financial results. The report showed that the company did not meet analyst expectations for its earnings or revenue.

The company posted an earnings per share (EPS) of -$0.15, which missed the consensus estimate of -$0.07. This figure represents the adjusted net loss per share. It marks a significant decline from the same period in 2025, when Star Equity Holdings reported an adjusted net income of $0.20 per share.

Star Equity Holdings also reported revenue of $54.9 million, falling short of the analyst expectation of $56.92 million. Despite missing the target, this revenue figure is a 54.6% increase compared to the second quarter of 2025. This shows that while the company did not meet market forecasts, its sales grew substantially year-over-year.

The company's overall profitability declined, with its net loss widening to $2.5 million from $0.7 million in the prior year. This results in a negative Price-to-Earnings (P/E) ratio of -3.89. A negative P/E ratio occurs when a company has a net loss, making it impossible to calculate a traditional earnings multiple.

From a financial health perspective, Star Equity Holdings has a Debt-to-Equity ratio of 0.44, which measures its debt compared to the value owned by shareholders. As highlighted by GlobeNewswire, the company also announced a merger agreement to acquire Harte Hanks, a move intended to expand its business services and revenue sources.

Market Overview
MDXH
MDxHealth S.A.
$0.81
74.89%
SURG
SurgePays, Inc.
$0.28
14.36%
VBIO
Valion Bio, Inc.
$0.19
11.59%
NU
Nu Holdings Ltd.
$15.23
9.33%
TSLL
Direxion Daily TSLA Bull 2X ETF
$8.76
1.39%
OTLK
Outlook Therapeutics, Inc.
$0.76
-14.90%
ONDS
Ondas Holdings Inc.
$9.24
3.70%
SPCX
Space Exploration Technologies Corp.
$140.00
-0.91%
INTC
Intel Corp.
$102.50
-1.97%
ONFO
Onfolio Holdings, Inc.
$2.59
12.12%